Journal
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Volume 334, Issue 3, Pages 1059-1065Publisher
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/jpet.110.168336
Keywords
-
Categories
Funding
- Ministry of Education, Science, Sports and Culture of Japan [12671451, 20791065, 20390412]
- Grants-in-Aid for Scientific Research [20791065, 20390412, 12671451] Funding Source: KAKEN
Ask authors/readers for more resources
The neurotransmitters serotonin (5-HT) and noradrenaline (NA) have important roles in suppressing nociceptive transmission in the spinal cord. In the present study, we determined the efficacy and nature of the antihypersensitivity effects of milnacipran, a 5-HT and NA reuptake inhibitor (SNRI), in the spinal cord in a rat model of postoperative pain. Sprague-Dawley rats were used in all experiments. An incision was made on the plantar aspect of the hind paw. Mechanical hypersensitivity was measured by determining the withdrawal threshold to von Frey filaments applied to the paw. Drugs were administered intrathecally 24 h after paw incision. Microdialysis studies of the dorsal horn of the lumbar spinal cord were also performed to measure 5-HT and NA levels after systemic injection of milnacipran. Milnacipran (1-30 mu g) produced dose-dependent antihypersensitivity effects. The effect lasted 6 h after the 30-mu g injection. Doses of 30 mu g or less produced no abnormal behavior. The peak antihypersensitivity effect of 10 mu g of milnacipran was blocked by intrathecal pretreatment with antagonists of the mu 2-adrenoceptor (idazoxan; 30 mu g) or 5-HT receptors (methysergide; 30 mu g). Intrathecal pretreatment with 30 mu g of naloxone, a mu-opioid receptor antagonist, did not reverse the effect of milnacipran. Isobolographic analysis indicated antinociceptive synergism between milnacipran and morphine. Microdialysis studies revealed that milnacipran increased both 5-HT and NA levels in the spinal dorsal horn. These findings suggest that the antihypersensitivity effect of intrathecal milnacipran in the postoperative pain model is monoamine- mediated. Combined administration of an SNRI with morphine might be a promising treatment to suppress postoperative hypersensitivity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available